Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Remdesivir Market Expected to Grow Between 2025 And 2029?

The market size for remdesivir has been on an exponential upward trend in the past few years, and the projections show a surge from $6.49 billion in 2024 to $8.52 billion in 2025, translating to a CAGR of 31.2%. The historic period’s growth is attributed to factors such as the increasing spread of COVID-19, escalating awareness about remdesivir, support from government, extensive clinical trials and research, as well as government purchases.

What Growth Rate Is Anticipated for the Remdesivir Market in the Coming Years?

The market size for remdesivir is predicted to experience substantial growth in the upcoming years. Forecasts predict expansion to $15.91 billion by 2029, with a compound annual growth rate (CAGR) of 16.9%. Several factors contribute to this projected growth over the forecast period, including ongoing response to COVID-19, the emergence of new variants, worldwide vaccination programs, readiness for pandemics, and global healthcare drives. Noteworthy trends for this forecast period encompass personalized treatment, combination treatment methodologies, the potential for scaled production, the use of telemedicine and remote patient monitoring, research into new potential uses, and exploration of alternative antiviral treatments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp

Who Are the Leading Companies in the Remdesivir Market?

Major companies operating in the remdesivir market include Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd, Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Pfizer Inc., Merck & Co. Inc., Cayman Chemical Company, Dr Reddy’s Laboratories Ltd., Inovio Pharmaceuticals, Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Berry Global Group, Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories

What Are the Key Drivers of the Remdesivir Market?

The growth of the remdesivir market is projected to be fueled by increasing government spending. This term refers to the total funds distributed by a government or public sector organization to fund its operations, programs, services, and projects. Government expenditure is a key factor in the growth and accessibility of Remdesivir, particularly during times of public health emergencies. The availability and affordability of this crucial antiviral medication can be improved by government contributions in the form of funding, regulatory support, purchasing power, and research investments. For example, in July 2023, the UK-based Government Digital Service reported that the central government’s current expenditure on services had risen from $876.47 billion to $963.74 billion for the 2022–23 period. The funds directed towards capital projects for services also increased from $81.37 billion for 2021–2022 to $104.72 billion for 2022–2023. Therefore, the escalating government expenditure is playing a vital role in propelling the remdesivir market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3253&type=smp

What Are the Key Market Segments in the Remdesivir Industry?

The remdesivir market covered in this report is segmented –

1) By Route Of Administration: Oral, Intravenous

2) By Dosage Form: Tablets, Frozen Solution, Lyophilized Solution

3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Other Distribution Channels

Subsegments:

1) By Oral: Tablet Formulation, Liquid Formulation

2) By Intravenous: Ready-To-Use Injectable, Lyophilized Powder For Injection

What Are the Latest Trends in the Remdesivir Market?

One main challenge to the market expansion is the exorbitant cost linked to the medication. The initial supply of 1.5 million doses from Remdesivir’s manufacturer, Gilead Sciences, was donated, but the firm indicated that they would need to start billing for the drug in order to maintain production. There’s a lot of conjecture about how the drug might be priced. The Institute for Clinical and Economic Review (ICER) estimates that the cost of Remdesivir would range from $4,580 to $5,080. The market’s growth is anticipated to be hampered by the higher pricing of Remdesivir.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/remdesivir-global-market-report

What Are the Key Regional Markets in the Remdesivir Industry?

The countries covered in the remdesivir market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3253

This Report Delivers Insight On:

1. How big is the remdesivir market, and how is it changing globally?

2. Who are the major companies in the remdesivir market, and how are they performing?

3. What are the key opportunities and risks in the remdesivir market right now?

4. Which products or customer segments are growing the most in the remdesivir market?

5. What factors are helping or slowing down the growth of the remdesivir market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model